Myeloma patients may soon skip hospital trips by Self-Injecting at home

This study looks at whether people with multiple myeloma can safely give themselves the drug daratumumab at home instead of going to the hospital. About 50 patients will take turns receiving the injection at home and at the clinic to compare the two approaches. The goal is to see if home self-administration is practical and safe, while also reducing the burden of frequent hospital visits.